BioAge Labs to Present at Upcoming Investor Conferences
BioAge Labs (NASDAQ: BIOA), a clinical-stage biotech company focused on developing therapeutics for metabolic diseases through aging biology, has announced its participation in two major upcoming investor conferences. The company's leadership, including CEO and co-founder Dr. Kristen Fortney and CFO Dr. Dov Goldstein, will attend:
• The Jefferies Global Healthcare Conference in New York (June 3-5, 2025) for one-on-one meetings
• The Goldman Sachs 46th Annual Global Healthcare Conference in Miami (June 9-11, 2025), featuring a fireside chat on June 9 at 3:20 PM EDT and one-on-one meetings. A webcast will be available and archived for 30 days on the company's investor relations website.
BioAge Labs (NASDAQ: BIOA), un'azienda biotecnologica in fase clinica specializzata nello sviluppo di terapie per le malattie metaboliche basate sulla biologia dell'invecchiamento, ha annunciato la sua partecipazione a due importanti conferenze per investitori in programma. Il management dell'azienda, incluso il CEO e cofondatore Dr. Kristen Fortney e il CFO Dr. Dov Goldstein, parteciperà a:
• La Jefferies Global Healthcare Conference a New York (3-5 giugno 2025) per incontri individuali
• La Goldman Sachs 46th Annual Global Healthcare Conference a Miami (9-11 giugno 2025), con una tavola rotonda informale il 9 giugno alle 15:20 EDT e incontri individuali. Una trasmissione in diretta sarà disponibile e archiviata per 30 giorni sul sito web delle relazioni con gli investitori dell'azienda.
BioAge Labs (NASDAQ: BIOA), una empresa biotecnológica en etapa clínica centrada en el desarrollo de terapias para enfermedades metabólicas a través de la biología del envejecimiento, ha anunciado su participación en dos importantes conferencias para inversores próximas. El equipo directivo de la empresa, incluyendo a la CEO y cofundadora Dra. Kristen Fortney y al CFO Dr. Dov Goldstein, asistirá a:
• La Jefferies Global Healthcare Conference en Nueva York (3-5 de junio de 2025) para reuniones individuales
• La Goldman Sachs 46th Annual Global Healthcare Conference en Miami (9-11 de junio de 2025), que incluirá una charla informal el 9 de junio a las 3:20 PM EDT y reuniones individuales. Habrá una transmisión en vivo disponible y archivada por 30 días en el sitio web de relaciones con inversores de la empresa.
BioAge Labs (NASDAQ: BIOA)는 노화 생물학을 통한 대사 질환 치료제 개발에 주력하는 임상 단계의 바이오테크 기업으로, 다가오는 두 건의 주요 투자자 컨퍼런스에 참여할 예정입니다. 회사의 리더십 팀인 CEO 겸 공동 창립자 Dr. Kristen Fortney와 CFO Dr. Dov Goldstein가 참석합니다:
• 2025년 6월 3일부터 5일까지 뉴욕에서 열리는 Jefferies Global Healthcare Conference에서 1:1 미팅 진행
• 2025년 6월 9일부터 11일까지 마이애미에서 개최되는 Goldman Sachs 46th Annual Global Healthcare Conference에서 6월 9일 오후 3시 20분(EDT)에 파이어사이드 채팅과 1:1 미팅 진행. 웹캐스트는 회사 투자자 관계 웹사이트에서 30일간 아카이브로 제공됩니다.
BioAge Labs (NASDAQ : BIOA), une société biotechnologique en phase clinique spécialisée dans le développement de traitements pour les maladies métaboliques via la biologie du vieillissement, a annoncé sa participation à deux importantes conférences investisseurs à venir. La direction de l'entreprise, incluant la PDG et cofondatrice Dr. Kristen Fortney ainsi que le CFO Dr. Dov Goldstein, assistera à :
• La Jefferies Global Healthcare Conference à New York (3-5 juin 2025) pour des réunions individuelles
• La Goldman Sachs 46th Annual Global Healthcare Conference à Miami (9-11 juin 2025), avec une discussion informelle le 9 juin à 15h20 EDT et des réunions individuelles. Un webcast sera disponible et archivé pendant 30 jours sur le site des relations investisseurs de la société.
BioAge Labs (NASDAQ: BIOA), ein biotechnologisches Unternehmen in der klinischen Phase, das sich auf die Entwicklung von Therapeutika für Stoffwechselerkrankungen durch Altersbiologie spezialisiert hat, hat seine Teilnahme an zwei wichtigen bevorstehenden Investorenkonferenzen angekündigt. Die Führung des Unternehmens, einschließlich CEO und Mitbegründerin Dr. Kristen Fortney sowie CFO Dr. Dov Goldstein, wird teilnehmen an:
• Der Jefferies Global Healthcare Conference in New York (3.-5. Juni 2025) für Einzelgespräche
• Der Goldman Sachs 46th Annual Global Healthcare Conference in Miami (9.-11. Juni 2025), mit einem Fireside-Chat am 9. Juni um 15:20 Uhr EDT sowie Einzelgesprächen. Ein Webcast wird verfügbar sein und für 30 Tage auf der Investor-Relations-Website des Unternehmens archiviert.
- None.
- None.
EMERYVILLE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conferences:
• Jefferies Global Healthcare Conference (New York, June 3–5, 2025): Kristen Fortney, PhD, CEO and co-founder, and Dov Goldstein, MD, CFO, will participate in one-on-one meetings.
• Goldman Sachs 46th Annual Global Healthcare Conference (Miami, June 9–11, 2025): Kristen Fortney, PhD, CEO and co-founder, and Dov Goldstein, MD, CFO, are scheduled to participate in a fireside chat on Monday, June 9, 2025 at 3:20–3:55 PM EDT, and will participate in one-on-one meetings. To access the live webcast of the presentation, register here.
Replays of the webcasts will be available in the investor section of the company's website at https://ir.bioagelabs.com/, and will be archived for 30 days following the presentations.
About BioAge Labs, Inc.
BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company’s pipeline includes novel, orally available, brain-penetrant small-molecule NLRP3 inhibitors to treat metabolic diseases and conditions driven by neuroinflammation, as well as novel APJ agonists for metabolic disorders. BioAge’s additional preclinical programs, which leverage insights from the Company’s proprietary discovery platform built on human longevity data, address key pathways involved in metabolic aging.
Contacts
PR: Chris Patil, media@bioagelabs.com
IR: Dov Goldstein, ir@bioagelabs.com
Partnering: partnering@bioagelabs.com
Web: https://bioagelabs.com
FAQ
When is BioAge Labs (BIOA) presenting at the Goldman Sachs Healthcare Conference 2025?
Which executives from BioAge Labs (BIOA) will attend the upcoming investor conferences?
Where can I watch BioAge Labs' (BIOA) Goldman Sachs conference presentation?
What type of company is BioAge Labs (BIOA)?
